K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: A combined analysis of 881 cases

Carcinogenesis

Volumn 20, Issue 8, 1999, Pages 1507-1510

  Huncharek, Michael ^a,b   Muscat, Joshua ^c   Geschwind, Jean Francois ^d  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Meta Analysis Research Group   (United States)

^c AMERICAN HEALTH FOUNDATION   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADJUVANT THERAPY; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; METASTASIS; ONCOGENE K RAS; PRIORITY JOURNAL; PROGNOSIS; STATISTICS; SURVIVAL TIME;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; GENES, RAS; HUMANS; LUNG NEOPLASMS; MUTATION; ODDS RATIO; PROGNOSIS;

EID: 0032855959     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.8.1507     Document Type: Article

References (27)

1. Ries, L.A.G., Kosary, C.L., Hankey, B.F. et al. (1997) SEER Cancer Statistics Review: 1973-1994, NIH Publication no. 97-2789. National Cancer Institute, Bethesda, MD.
2. Ihde, D.C. and Minna, J.D. (1991) Non-small cell lung cancer. Part II. Treatment. In Haskell, C.C. (ed.) Current Problems in Cancer. Mosby Year Book, St Louis, MO, pp. 107-154.
3. Vogelstein, B. and Kinzler, K.W. (1993) The multi-step nature of cancer. Trends Genet., 9, 138-141.
4. Sandberg, A.A. (1990) The Chromosomes in Human Cancer and Leukemia, 2nd Edn. Elsevier North Holland, New York, NY.
5. Rodenhuis, S. (1992) Ras in human tumors. Semin. Cancer Biol., 3, 241-250.
6. Barbacid, M. (1987) Ras genes. Annu. Rev. Biochem., 56, 799-821.
7. Siegfried, J.M., Gillespie, A.T., Mera, R. et al. (1997) Prognostic value of specific k-ras mutations in lung adenocarcinoma. Cancer Epidemiol. Biomarkers Prev., 6, 841-847.
8. Hedges, L.V. and Olkin, I. (1985) Statistical Methods for Meta-Analysis. Academic Press, San Diego, CA.
9. Cooper, H. and Hedges, L.V. (1994) The Handbook of Research Synthesis. Russell Sage Foundation, New York, NY.
10. Greenland, S. (1987) Quantitiative methods in the review of epidemiologic literature. Epidemiol. Rev., 9, 1-30.
11. Isobe, T., Hiyama, K., Yoshida, Y. et al. (1994) Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection. Jpn J. Cancer Res., 85, 1240-1246.
12. Slebos, R.J.C., Kibbelaar, R.E., Dalesio, O. et al. (1990) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323, 561-565.
13. Silini, E.M., Bosi, F., Pellegata, N.S. et al. (1994) K-ras gene mutation; an unfavorable prognostic marker in stage I lung adenocarcinoma. Virchows Arch., 424, 367-373.
14. Mitsudomi, T., Viallet, J., Mulshine, J.L. et al. (1991) Mutations of ras genes distinguish a subset of non-small cell lung cancer cell lines from small cell lung cancer cell lines. Oncogene, 6, 1353-1362.
15. Kern, J.A., Slebos, RJ., Top, B. et al. (1994) C-erb-2 expression and codon 12 k-ras mutations both predict shortened survival for patients with pulmonary adenocarcinoma. J. Clin. Invest., 93, 516-520.
16. Rosell, R., Monzo, M., Pifarre, A. et al. (1996) Molecular staging of non-small cell lung cancer according to k-ras genotypes. Clin. Cancer Res., 2, 1083-1086.
17. Sugio, K., Ishida, J., Yokoyama, H. et al. (1992) Ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res., 52, 2903-2906.
18. Cho, J.Y., Kim, J.H., Lee, Y.H. et al. (1997) Correlation between k-ras gene mutation and prognosis of patients with non-small cell lung carcinoma. Cancer, 79, 462-467.
19. Mitsudomi, T., Steinberg, S.M., Oie, H.K, et al. (1991) Ras gene mutations in non-small cell lung cancer are associated with shortened survival irrespective of treatment intent. Cancer Res., 51, 4990-5002.
20. Rosell, R., Monzo, M., Molina, E et al. (1995) K-ras geneotypes and prognosis in non-small cell lung cancer. Ann. Oncol., 6 (suppl. 3), S15-S20.
21. Rodenhuis, S., Boerringter, L., Top, B. et al. (1997) Mutational activation of the k-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung; a prospective study. J. Clin. Oncol., 15, 285-291.
22. Rosell, R., Molina, F., Moreno, I. et al. (1995) Mutated k-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIa non-small cell lung cancer. Lung Cancer, 12 (suppl. 1), S59-S70.
23. Rosell, R., Li, S., Skacel, Z. et al. (1993) Prognostic impact of mutated k-ras gene in surgically resected non-small cell lung cancer patients. Oncogene, 8, 2407-2412.
24. Fukuyama, Y., Mitsudomi, T., Sugio, K. et al. (1997) K-ras and p53 mutations are an independent unfavorable prognostic indicator in patients with non-small cell lung cancer. Br. J. Cancer, 75, 1125-1130.
25. Rodenhuis, S. Slebos, R.J., Boot, A.J. et al. (1988) Incidence and possible clinical significance of k-ras oncogene activation in adenocarcinoma in the human lung. Cancer Res., 48, 5738-5741.
26. Rosell, R., Pifarre, A., Monzo, M. et al. (1997) Reduced survival in patients with stage I non-small cell lung cancer associated with DNA-replication errors. Int. J. Cancer, 74, 330-334.
27. Kashii, T., Mizushima, Y., Lima, E.Q. et al. (1995) Studies on clinicopathological features of lung cancer patients with k-ras/p53 gene alteration; comparison between younger and older groups. Oncology, 52, 219-225.